How to Get Mavenclad (Cladribine Tablets) Covered by Cigna in Illinois: Complete Renewal Guide with Appeals Process
Quick Answer: Mavenclad (cladribine tablets) requires annual prior authorization renewal with Cigna in Illinois. Submit updated labs, MRI results, and proof of treatment response through your neurologist 2-4 weeks before your current approval expires. If denied, you have 180 days for internal appeals, then 30 days for Illinois external review.